NCT05268705

Brief Summary

A randomized, open-label, three-arm crossover study will be conducted. The aim of the study is to determine the effect of different isocaloric diet macronutrient compositions (High-carbohydrate-Low-fat-Low-protein (HCLFLP), Low-carbohydrate-High-fat-Low-protein (LCHFLP), Low-carbohydrate-Low-fat-High-protein (LCLFHP)) on plasma glucose dynamics in everyday life and during fasted exercise in persons with type 1 diabetes. Our hypothesis is that a HCLFLP diet reduce the decrease in plasma glucose from start to end of fasted exercise compared with a LCHFLP diet. Secondary a LCHFLP compared with a LCLFHP diet does not reduces the decrease in plasma glucose from start to end of fasted exercise. The current study will contribute with new knowledge about the importance of the compositions of a low-carbohydrate diet on glucose dynamics and the influence on plasma glucose during and after cycling in fasted state.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

February 3, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 7, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2022

Completed
Last Updated

January 9, 2023

Status Verified

January 1, 2023

Enrollment Period

9 months

First QC Date

January 31, 2022

Last Update Submit

January 6, 2023

Conditions

Keywords

Type 1 diabetesNutritionExerciseInsulin pump

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint is the difference between study arms in difference from start to end plasma glucose concentration during 45 min fasted cycling (assessed by YSI (Yellow Spring Instruments 2900 STAT Plus)).

    45 min

Secondary Outcomes (29)

  • Mean CGM glucose level assessed by CGM during diet interventions

    7 days

  • Time spent < 3.9 mmol/l assessed by CGM during diet interventions

    7 days

  • Time spent < 3.0 mmol/l assessed by CGM during diet interventions

    7 days

  • Time spent 3.9-10.0 mmol/l assessed by CGM during diet interventions

    7 days

  • Time spent > 10.0 mmol/l assessed by CGM during diet interventions

    7 days

  • +24 more secondary outcomes

Study Arms (3)

High-carbohydrate-low-fat-low-protein diet

ACTIVE COMPARATOR
Other: 7-day diet

Low-carbohydrate-high-fat-low-protein diet

ACTIVE COMPARATOR
Other: 7-day diet

Low-carbohydrate-low-fat-high-protein diet

ACTIVE COMPARATOR
Other: 7-day diet

Interventions

The participants must follow a 7-day high-carbohydrate-low-fat-low-protein diet before the inclinic study visit at day 8. The in-clinic study visits are identical for all the three study arms.

High-carbohydrate-low-fat-low-protein diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Type 1 diabetes ≥ 5 years
  • Insulin pump use ≥ 1 year
  • Use of intermittently scanned continuous glucose monitoring (isCGM) or continuous glucose monitoring (CGM) ≥ 3 months
  • HbA1c ≤ 69 mmol/mol (8.5%)
  • Self-reported hypoglycemia awareness
  • Exercising at least 30 minutes at moderate or vigorous intensity two times per week.

You may not qualify if:

  • Use of anti-diabetic medicine (other than insulin), corticosteroids or other drugs affecting glucose metabolism during the study period or within 30 days prior to study start
  • Use of a hybrid closed-loop system
  • Females who are pregnant, breast-feeding or intend to become pregnant during the study period
  • Ischemic heart disease
  • Severe asthma
  • Other concomitant medical or psychological condition that according to the investigator's assessment makes the individual unsuitable for study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Steno Diabetes Center Copenhagen

Herlev, 2730, Denmark

Location

Related Publications (1)

  • McCarthy OM, Kristensen KB, Christensen MB, Schmidt S, Ranjan AG, Nicholas C, Bain SC, Norgaard K, Bracken R. Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapy. Diabetes Obes Metab. 2023 Mar;25(3):878-888. doi: 10.1111/dom.14938. Epub 2023 Jan 3.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Motor Activity

Interventions

Diet

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Kirsten Nørgaard, Professor

    Steno Diabetes Center Copenhagen, Clinical Reseach, Diabetes Technology Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2022

First Posted

March 7, 2022

Study Start

February 3, 2022

Primary Completion

November 8, 2022

Study Completion

November 8, 2022

Last Updated

January 9, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations